Dr. Sara Katharine Tedeschi, MD

Dr. Tedeschi practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Tedeschi's NPI, 1508186446, was assigned on June 2, 2010. Dr. Tedeschi graduated from Vanderbilt University School of Medicine in 2010. Dr. Tedeschi holds Massachusetts license 252324.

Dr. Tedeschi's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Tedeschi's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Tedeschi is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Tedeschi to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tedeschi practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tedeschi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tedeschi is licensed in Massachusetts.

CMS data shows 101 Medicare services from Dr. Tedeschi across 2 procedure codes in 2024, all of them office visits, for 64 Medicare patients. Medicare paid $8,123 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Tedeschi in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have arthritis, and 72% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tedeschi's median patient age at 72, with 73% women.

In 2024, Dr. Tedeschi wrote 627 Medicare Part D claims for 77 patients. 75% of them were for generic drugs. CMS names the drug for 469 of them, across 20 drugs with 11 or more claims each, at $567,842 in total drug cost. In 2023, CMS named 392 claims across 16 drugs.

Dr. Tedeschi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tedeschi as offering telehealth.

Dmand AI links 106 papers to Dr. Tedeschi, published from 2010 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Chondrocalcinosis, Arthritis, Rheumatoid and Calcium Pyrophosphate. Dr. Tedeschi has published most often in Arthritis Care Res (Hoboken). Dr. Tedeschi's most frequent co-authors are Karen H. Costenbader, MD, MPH, Jeffrey A. Sparks, MD and Bing Lu, MD.

CMS Open Payments shows 24 general payments to Dr. Tedeschi from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $11,581.

Dr. Tedeschi graduated from Vanderbilt University School of Medicine in 2010.